Genetics discovery to help fight 'black fever'

January 8, 2013, University of Western Australia

Scientists—including a geneticist at The University of Western Australia—are a step closer to developing a vaccine against a fatally infectious parasite carried in the bite of sandflies.

Visceral leishmaniasis, also known as black fever, is the second-largest parasitic killer in the world after malaria.  The parasite migrates to organs such as liver, spleen and bone marrow and if left untreated will almost always be fatal. Symptoms include fever, weight loss, mucosal ulcers, fatigue, anemia and substantial swelling of the liver and spleen.

Leishmaniasis affects 12 million people and there are an estimated 1.5 million new cases annually mainly in India, Bangladesh, Nepal, Sudan, South Sudan, Ethiopia and Brazil.

UWA Winthrop Professor Jenefer Blackwell, Head, Genetics and Health, Telethon Institute for Child Health Research, was a senior author of a big international study which has uncovered a single major genetic risk factor for visceral leishmaniasis.  She led the LeishGEN Consortium that carried out all of the field work and sample collection, first from the Cambridge Institute for Medical Research at the University of Cambridge and later from UWA and TICHR.  She was also a member of the Wellcome Trust Case Control Consortium which carried out the .

The study was published online this week in .

With scientists from India, Brazil, UK, Australia and the USA, Professor Blackwell identified variation in a specific region of the major immune response locus, known to immunologists as the major histocompatibility complex (MHC), as the single most important factor for disease. 

The researchers compared genomes of 1346 people suffering from disease in India and Brazil against those of 2702 healthy controls.  The findings were confirmed in an independent cohort of 941 cases and 990 healthy controls from India. 

Teams in Australia, UK and the USA are using the results in to study the way the immune system interacts with the disease in mice.  "Earlier genetic studies of in inbred mice allowed us to clearly demonstrate the importance of the MHC in regulating this disease," Professor Blackwell said. 

"Now, major advances in human genetics and the ability to compare the genomes of large numbers of people with and without the disease have allowed us to identify the precise molecular basis to this MHC control in humans.  This will have a major impact on refining research towards the ultimate goal of a vaccine."

Explore further: First vaccine against fatal visceral leishmaniasis enters clinical trial

Related Stories

First vaccine against fatal visceral leishmaniasis enters clinical trial

February 23, 2012
The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat ...

Vaccine against black fever being tested

April 23, 2012
After more than two decades of research, scientists are testing the first vaccine against the deadliest form of a disease that infects more than 12 million people worldwide.

Major project to implement new treatments to boost kala-azar elimination strategies

November 7, 2011
A comprehensive four-year project including over 10,000 patients in clinical and pharmacovigilance studies for diagnosis and treatment of visceral leishmaniasis (VL, also known as kala-azar) in India and Bangladesh was launched ...

Recommended for you

Peers' genes may help friends stay in school, new study finds

January 18, 2018
While there's scientific evidence to suggest that your genes have something to do with how far you'll go in school, new research by a team from Stanford and elsewhere says the DNA of your classmates also plays a role.

Can mice really mirror humans when it comes to cancer?

January 18, 2018
A new Michigan State University study is helping to answer a pressing question among scientists of just how close mice are to people when it comes to researching cancer.

Two new breast cancer genes emerge from Lynch syndrome gene study

January 18, 2018
Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes—MSH6 and PMS2—approximately doubles a woman's risk of developing breast ...

A centuries-old math equation used to solve a modern-day genetics challenge

January 18, 2018
Researchers developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests. The work was published this month in Genetics in Medicine.

Epigenetics study helps focus search for autism risk factors

January 16, 2018
Scientists have long tried to pin down the causes of autism spectrum disorder. Recent studies have expanded the search for genetic links from identifying genes toward epigenetics, the study of factors that control gene expression ...

Group recreates DNA of man who died in 1827 despite having no body to work with

January 16, 2018
An international team of researchers led by a group with deCODE Genetics, a biopharmaceutical company in Iceland, has partly recreated the DNA of a man who died in 1827, despite having no body to take tissue samples from. ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

dogbert
1 / 5 (1) Jan 08, 2013
Excellent research.

Let us hope this leads to a significant therapy if not a cure.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.